Status:
COMPLETED
Toxicological Screening by GC-MS Among Children Admitted for a First Afebrile Seizure
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Afebrile Seizure (Finding)
Eligibility:
All Genders
1-15 years
Phase:
NA
Brief Summary
Before the age of 14 years, 1% of the paediatric population will develop a seizure. The only systematically required complementary examination is an electroencephalogram (EEG). Additional biological o...
Detailed Description
Before the age of 14 years, 1% of the paediatric population will develop a seizure. The only systematically required complementary examination is an electroencephalogram (EEG). Additional biological o...
Eligibility Criteria
Inclusion
- Being aged between 1 month and 15 years for boys and 1 month and 11 years for girls
- Any first episode of afebrile seizure, independent of duration, type (generalized or not) occurring in children without any previous neurological history and admitted to Toulouse level III paediatric emergency unit (University Children Hospital, Toulouse)
- Consent form signed by parents or legal guardian
Exclusion
- Patient transferred from another hospital
- Absence of consent form signed by parents or legal guardian
- Seizure in a febrile context at the moment of inclusion
- Known history of neurological disorders
- Any kind of diagnosed epilepsy
- Renal or hepatocellular insufficiency
- Recent head trauma
- Coagulation disorders (hemophilia, secondary or primary thrombopenia)
- Known exposure to toxic molecules
Key Trial Info
Start Date :
December 19 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 6 2020
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT03310697
Start Date
December 19 2017
End Date
October 6 2020
Last Update
October 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital des enfants
Toulouse, Midi-Pyrénées, France, 31059